Teva asks the Supreme Court to block competitors

• Lawyers for Teva Pharmaceutical Industries (TEVA -2%) ask the Supreme Court to stop a lower court ruling allowing generic Copaxone makers to launch offerings as early as May.
• The Court accepted the case on March 31 but will not hear oral arguments until October and a ruling might not happen until mid-2015.
• Teva believes it will suffer "irreparable harm" if other generics are allowed to market.
• (NASDAQ:MNTA)